264 related articles for article (PubMed ID: 25264771)
1. Reorganisation of the salivary mucin network by dietary components: insights from green tea polyphenols.
Davies HS; Pudney PD; Georgiades P; Waigh TA; Hodson NW; Ridley CE; Blanch EW; Thornton DJ
PLoS One; 2014; 9(9):e108372. PubMed ID: 25264771
[TBL] [Abstract][Full Text] [Related]
2. Degradation of MUC7 and MUC5B in human saliva.
Takehara S; Yanagishita M; Podyma-Inoue KA; Kawaguchi Y
PLoS One; 2013; 8(7):e69059. PubMed ID: 23874867
[TBL] [Abstract][Full Text] [Related]
3. MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.
Szkaradkiewicz-Karpińska AK; Ronij A; Goślińska-Kuźniarek O; Przybyłek I; Szkaradkiewicz A
Int J Med Sci; 2019; 16(2):241-246. PubMed ID: 30745804
[No Abstract] [Full Text] [Related]
4. Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness.
Chaudhury NM; Proctor GB; Karlsson NG; Carpenter GH; Flowers SA
Mol Cell Proteomics; 2016 Mar; 15(3):1048-59. PubMed ID: 26631508
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
Wickström C; Christersson C; Davies JR; Carlstedt I
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of astringency: Structural alteration of the oral mucosal pellicle by dietary tannins and protective effect of bPRPs.
Ployon S; Morzel M; Belloir C; Bonnotte A; Bourillot E; Briand L; Lesniewska E; Lherminier J; Aybeke E; Canon F
Food Chem; 2018 Jul; 253():79-87. PubMed ID: 29502847
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva.
Rousseau K; Kirkham S; Johnson L; Fitzpatrick B; Howard M; Adams EJ; Rogers DF; Knight D; Clegg P; Thornton DJ
Biochem J; 2008 Aug; 413(3):545-52. PubMed ID: 18426393
[TBL] [Abstract][Full Text] [Related]
8. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.
Rousseau K; Wickstrom C; Whitehouse DB; Carlstedt I; Swallow DM
Hybrid Hybridomics; 2003 Oct; 22(5):293-9. PubMed ID: 14678646
[TBL] [Abstract][Full Text] [Related]
9. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
[TBL] [Abstract][Full Text] [Related]
10. Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva.
Raynal BD; Hardingham TE; Thornton DJ; Sheehan JK
Biochem J; 2002 Mar; 362(Pt 2):289-96. PubMed ID: 11853536
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of salivary mucins in children with deciduous and mixed dentition: comparative analysis between high and low caries-risk groups.
Angwaravong O; Pitiphat W; Bolscher JG; Chaiyarit P
Clin Oral Investig; 2015 Nov; 19(8):1931-7. PubMed ID: 25689982
[TBL] [Abstract][Full Text] [Related]
12. The lipophilic cyclic peptide cyclosporin A induces aggregation of gel-forming mucins.
Kishimoto H; Ridley C; Thornton DJ
Sci Rep; 2022 Apr; 12(1):6153. PubMed ID: 35418571
[TBL] [Abstract][Full Text] [Related]
13. The green tea polyphenol (-)-epigallocatechin gallate precipitates salivary proteins including alpha-amylase: biochemical implications for oral health.
Hara K; Ohara M; Hayashi I; Hino T; Nishimura R; Iwasaki Y; Ogawa T; Ohyama Y; Sugiyama M; Amano H
Eur J Oral Sci; 2012 Apr; 120(2):132-9. PubMed ID: 22409219
[TBL] [Abstract][Full Text] [Related]
14. Salivary gel-forming mucin MUC5B--a nutrient for dental plaque bacteria.
Wickström C; Svensäter G
Oral Microbiol Immunol; 2008 Jun; 23(3):177-82. PubMed ID: 18402602
[TBL] [Abstract][Full Text] [Related]
15.
Chahal G; Quintana-Hayashi MP; Gaytán MO; Benktander J; Padra M; King SJ; Linden SK
Front Cell Infect Microbiol; 2022; 12():889711. PubMed ID: 35782137
[No Abstract] [Full Text] [Related]
16. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
[TBL] [Abstract][Full Text] [Related]
17. Analytical ultracentrifugation in saliva research: Impact of green tea astringency and its significance on the in-vivo aroma release.
Dinu V; Liu C; Ali J; Ayed C; Gershkovich P; Adams GG; Harding SE; Fisk ID
Sci Rep; 2018 Sep; 8(1):13350. PubMed ID: 30190600
[TBL] [Abstract][Full Text] [Related]
18. A predictive model for astringency based on in vitro interactions between salivary proteins and (-)-Epigallocatechin gallate.
Ye QQ; Chen GS; Pan W; Cao QQ; Zeng L; Yin JF; Xu YQ
Food Chem; 2021 Mar; 340():127845. PubMed ID: 32889218
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
[TBL] [Abstract][Full Text] [Related]
20. N-terminal cleavage of the salivary MUC5B mucin. Analogy with the Van Willebrand propolypeptide?
Wickström C; Carlstedt I
J Biol Chem; 2001 Dec; 276(50):47116-21. PubMed ID: 11602588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
